Key study of Grail’s cancer detection test fails in setback for company
Cancer Blood Test Setback: What the Grail Study Means for Early Detection A recent study involving Grail’s Galleri blood test, designed for early cancer detection, has revealed the test did not meet its primary goal within England’s National Health Service (NHS) trial. This news sent Grail’s shares down 47% in after-hours trading, raising questions about … Read more